Categories AlphaGraphs, Earnings, Health Care
MDT Earnings: Highlights of Medtronic’s Q4 2022 results
Medical device maker Medtronic plc (NYSE: MDT) has reported an increase in profit for the fourth quarter of 2022, despite a modest decline in revenues.
The company said revenues declined 1% year-over-year to $8.1 billion in the final three months of fiscal 2022. The top line was hurt by weakness in the Medical-Surgical and Neurosciences divisions, which more than offset positive performance by the Cardiovascular segment.
Meanwhile, adjusted earnings increased 2% to $1.52 per share. Reported net income, including special items, was $1.49 billion or $1.10 per share, compared to $1.36 billion or $1.00 per share in the fourth quarter of 2021.
Read management/analysts’ comments on quarterly reports
“We remain keenly focused on delivering innovation-driven growth with a robust pipeline of technologies in fast-growing markets, and we’re committed to creating strong shareholder value through strategic capital allocation and active portfolio management,” said Geoff Martha, chief executive officer of Medtronics.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
